Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. (Q34602596)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

review article

1 reference

title

Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Linda P Dwoskin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Anthony S Rauhut

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Kelley A King-Pospisil

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Michael T Bardo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

178-207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

Conditioned place preference: what does it add to our preclinical understanding of drug reward?

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Tobacco cessation among patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Major depression following smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

The effect of bupropion sustained-release on cigarette craving after smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Dramatic decreases in brain reward function during nicotine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Inhibition of nicotine-induced hippocampal norepinephrine release in rats by alpha-conotoxins MII and AuIB microinjected into the locus coeruleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

The safety of newer antidepressants in pregnancy and breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Smoking, smoking cessation, and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Bupropion in depression. II. The role of metabolites in clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Bupropion overdose: QTc prolongation and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Animal model of depression: tests of three structurally and pharmacologically novel antidepressant compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Characteristics of conditioned taste aversion produced by nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Antidepressants and seizures: emphasis on newer agents and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Rewarding drugs produce taste avoidance, but not taste aversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of smoking withdrawal symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Bupropion increases striatal vesicular monoamine transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Reboxetine: attenuation of intravenous nicotine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Bupropion effects on aggressiveness and anxiety in OF1 male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

The reinstatement model of drug relapse: history, methodology and major findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

The effect of bupropion on nicotine craving and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

National Patterns of Medication Treatment for Depression, 1987 to 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Bupropion and paroxetine differentially influence cardiovascular and neuroendocrine responses to stress in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Antagonism of the behavioral effects of cocaine and d-amphetamine by prazosin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

How does bupropion work as a smoking cessation aid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Anorectic and behavioural effects of bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Perceptual changes with bupropion, a novel antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2006.00178.X

Blockade of nicotine self-administration with nicotinic antagonists in rats.

21 January 2018

1 reference

12 December 2020

Effects of antidepressants in rats trained to discriminate the beta-2 adrenergic agonist clenbuterol.

1 reference

12 December 2020

Bupropion: a review of its use in the management of smoking cessation

1 reference

12 December 2020

Antagonism of stimulus properties of nicotine by dihydro-beta-erythroidine (DHbetaE) in rats.

1 reference

12 December 2020

Bupropion is a nicotinic antagonist.

1 reference

12 December 2020

CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.

1 reference

12 December 2020

Bupropion overdose in an adolescent

1 reference

12 December 2020

Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation

1 reference

12 December 2020

Acute doses of d-amphetamine and bupropion increase cigarette smoking

1 reference

12 December 2020

Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats

1 reference

12 December 2020

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

1 reference

12 December 2020

Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression

1 reference

12 December 2020

Recreational bupropion abuse in a teenager

1 reference

12 December 2020

Bupropion (Zyban) toxicity

1 reference

12 December 2020

Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department.

1 reference

12 December 2020

Prevalence of sexual dysfunction among newer antidepressants.

1 reference

12 December 2020

Change from the CYP2D6 extensive metabolizer to the poor metabolizer phenotype during treatment With bupropion

1 reference

12 December 2020

Nicotine-like discriminative stimulus effects of bupropion in rats

1 reference

12 December 2020

Nicotine and bupropion share a similar discriminative stimulus effect

1 reference

12 December 2020

Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors

1 reference

12 December 2020

Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors

1 reference

12 December 2020

Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine

1 reference

12 December 2020

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms

1 reference

12 December 2020

Bupropion exposures: clinical manifestations and medical outcome

1 reference

12 December 2020

Investigating the actions of bupropion on dependence-related effects of nicotine in rats

1 reference

12 December 2020

Bupropion poisoning: a case series

1 reference

12 December 2020

Antidepressant-like effects in various mice strains in the forced swimming test.

1 reference

12 December 2020

Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.

1 reference

12 December 2020

Cytochrome P450 2D6 polymorphism and character traits

1 reference

12 December 2020

Effect of bupropion on nicotine self-administration in rats

1 reference

12 December 2020

Review of bupropion for smoking cessation

1 reference

12 December 2020

Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats

1 reference

12 December 2020

Antidepressant-like effects in various mice strains in the tail suspension test

1 reference

12 December 2020

Behavioral and biochemical investigations of bupropion metabolites

1 reference

12 December 2020

Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms

1 reference

12 December 2020

Effects of bupropion on core body temperature of mice

1 reference

12 December 2020

Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum

1 reference

12 December 2020

Nicotine as a signal for the presence or absence of sucrose reward: a Pavlovian drug appetitive conditioning preparation in rats

1 reference

12 December 2020

Sustained release bupropion overdose: an important cause of prolonged symptoms after an overdose

1 reference

12 December 2020

A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees

1 reference

12 December 2020

Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting

1 reference

12 December 2020

Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response

1 reference

12 December 2020

Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study

1 reference

12 December 2020

Bupropion insufflation in a teenager

1 reference

12 December 2020

Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors

1 reference

12 December 2020

Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression

1 reference

12 December 2020

Bupropion and breastfeeding: a case of a possible infant seizure.

1 reference

12 December 2020

Pharmacokinetics of bupropion and its metabolites in haemodialysis patients who smoke. A single dose study

1 reference

12 December 2020

A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future

1 reference

12 December 2020

Organic mental disorders associated with bupropion in three patients

1 reference

12 December 2020

Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication

1 reference

12 December 2020

Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice

1 reference

12 December 2020

Acute psychosis following sustained release bupropion overdose

1 reference

12 December 2020

The relationship between antidepressant medication use and rate of suicide

1 reference

12 December 2020

Steady-state pharmacokinetics of bupropion SR in juvenile patients

1 reference

12 December 2020

Bupropion SR for the treatment of postpartum depression: a pilot study

1 reference

12 December 2020

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study

1 reference

12 December 2020

Bupropion-induced convulsions: preclinical evaluation of antiepileptic drugs.

1 reference

12 December 2020

Inhibition of CYP2D6 activity by bupropion

1 reference

12 December 2020

Falling backward in two elderly patients taking bupropion

1 reference

12 December 2020

HPLC assay for bupropion and its major metabolites in human plasma

1 reference

12 December 2020

Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion

1 reference

12 December 2020

Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats

1 reference

12 December 2020

Anticraving medications for relapse prevention: a possible new class of psychoactive medications

1 reference

12 December 2020

Medication development for addictive disorders: the state of the science

1 reference

12 December 2020

Catatonia associated with bupropion treatment.

1 reference

12 December 2020

Reversal of triazolam tolerance and withdrawal-induced hyperlocomotor activity and anxiety by bupropion in mice

1 reference

12 December 2020

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials

1 reference

12 December 2020

A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine

1 reference

12 December 2020

Bupropion attenuates nicotine abstinence syndrome in the rat.

1 reference

12 December 2020

Use of bupropion in combination with serotonin reuptake inhibitors

1 reference

12 December 2020

Adverse effects associated with extra doses of bupropion

1 reference

12 December 2020

Bupropion: risks and benefits

1 reference

12 December 2020

Population pharmacokinetic analysis of drug-drug interactions among risperidone, bupropion, and sertraline in CF1 mice

1 reference

12 December 2020

Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration

1 reference

12 December 2020

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations

1 reference

12 December 2020

Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice

1 reference

12 December 2020

Recognizing and treating depression in children and adolescents

1 reference

12 December 2020

Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population

1 reference

12 December 2020

Preexposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats

1 reference

12 December 2020

Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study

1 reference

12 December 2020

Pharmacological characterization of the discriminative-stimulus effects of GBR 12909

1 reference

12 December 2020

Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity

1 reference

12 December 2020

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

1 reference

12 December 2020

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

1 reference

12 December 2020

Bupropion for the treatment of nicotine withdrawal and craving

1 reference

12 December 2020

A 102-center prospective study of seizure in association with bupropion

1 reference

12 December 2020

Double-blind comparison of bupropion and fluoxetine in depressed outpatients

1 reference

12 December 2020

Antidepressant profile of bupropion and three metabolites in mice

1 reference

12 December 2020

Chronic antidepressant and clonidine treatment effects on conflict behavior in the rat.

1 reference

12 December 2020

Seizures and bupropion: a review

1 reference

12 December 2020

Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys

1 reference

12 December 2020

Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.

1 reference

12 December 2020

Pharmacologic characterization of nicotine-induced conditioned place preference.

1 reference

12 December 2020

Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism

1 reference

12 December 2020

Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs

1 reference

12 December 2020

Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons

1 reference

12 December 2020

Pharmacological significance of the species differences in bupropion metabolism

1 reference

12 December 2020

Treatment of bulimia with bupropion: a multicenter controlled trial

1 reference

12 December 2020

Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule.

1 reference

12 December 2020

The effects of long-term administration of antidepressant drugs on intracranial self-stimulation responding in rats

1 reference

12 December 2020

Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose

1 reference

12 December 2020

The conditioned place preference paradigm in rats: effect of bupropion

1 reference

12 December 2020

Must antidepressants be anticholinergic to inhibit muricide?

1 reference

12 December 2020

Effect of bupropion on dopamine and 5-hydroxytryptamine-mediated behaviour in mice

1 reference

12 December 2020

Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain

1 reference

12 December 2020

Bupropion and amitriptyline in the treatment of depressed patients.

1 reference

12 December 2020

Long-term efficacy and safety of bupropion

1 reference

12 December 2020

The cardiovascular profile of bupropion.

1 reference

12 December 2020

Overview of clinically significant adverse reactions to bupropion

1 reference

12 December 2020

Bupropion: clinical assay for amphetamine-like abuse potential.

1 reference

12 December 2020

Preclinical toxicology of bupropion: an overview.

1 reference

12 December 2020

Studies of bupropion's mechanism of antidepressant activity

1 reference

12 December 2020

Metabolism and kinetics of bupropion

1 reference

12 December 2020

Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection

1 reference

12 December 2020

Bupropion hydrochloride.

1 reference

12 December 2020

Stimulus properties of antidepressants in the rat.

1 reference

12 December 2020

Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects

1 reference

12 December 2020

Relationship between bupropion disposition and dopamine uptake inhibition in rats and mice.

1 reference

12 December 2020

Effects of dopamine uptake inhibitors on schedule-controlled behavior in the squirrel monkey.

1 reference

12 December 2020

Bupropion: a review of its mechanism of antidepressant activity

1 reference

12 December 2020

Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism

1 reference

12 December 2020

Release of dopamine via the human transporter

1 reference

12 December 2020

Comparison of bupropion and trazodone for the treatment of major depression

1 reference

12 December 2020

Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains.

1 reference

12 December 2020

The discriminative stimulus effects of cocaine in pigeons.

1 reference

12 December 2020

Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion

1 reference

12 December 2020

Bupropion overdose: a 3-year multi-center retrospective analysis.

1 reference

12 December 2020

Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis

1 reference

12 December 2020

Excretion of bupropion in breast milk

1 reference

12 December 2020

The discriminative stimulus effects of methamphetamine in pigeons.

1 reference

12 December 2020

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

12 December 2020

Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression

1 reference

12 December 2020

Bupropion plasma levels and CYP2D6 phenotype

1 reference

12 December 2020

Bupropion induces sniffing: a possible dopaminergic mechanism

1 reference

12 December 2020

Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.

1 reference

12 December 2020

Conditioned taste aversions and drugs of abuse: a reinterpretation

1 reference

12 December 2020

Fatal bupropion overdose

1 reference

12 December 2020

Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography

1 reference

12 December 2020

Addressing women's concerns about weight gain due to smoking cessation

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats.

1 reference

12 December 2020

Bupropion sustained release and smoking cessation.

1 reference

12 December 2020

Discriminative stimulus effects of a cocaine/heroin "speedball" combination in rhesus monkeys

1 reference

12 December 2020

A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients

1 reference

12 December 2020

Effects of antidepressant drugs on rats bred for low activity in the swim test

1 reference

12 December 2020

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

12 December 2020

The existence of tolerance to and cross-tolerance between d-amphetamine and methylphenidate for their effects on milk consumption and on differential-reinforcement-of-low-rate performance in the rat.

1 reference

12 December 2020

alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.

1 reference

12 December 2020

Bupropion slow-release response in depression: diagnosis and biochemistry

1 reference

12 December 2020

Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine

1 reference

12 December 2020

10.1111/J.1527-3458.2006.00178.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17227286%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

PubMed publication ID

17227286

1 reference